Growth Metrics

United Health Products (UEEC) Return on Capital Employed (2016 - 2025)

United Health Products (UEEC) has disclosed Return on Capital Employed for 14 consecutive years, with 1.45% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Capital Employed rose 65.0% to 1.45% in Q3 2025 year-over-year; TTM through Sep 2025 was 1.45%, a 65.0% increase, with the full-year FY2024 number at 1.47%, down 1.0% from a year prior.
  • Return on Capital Employed was 1.45% for Q3 2025 at United Health Products, down from 1.62% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 844.43% in Q1 2021 to a low of 0.79% in Q3 2024.
  • A 5-year average of 51.5% and a median of 1.51% in 2023 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: soared 83841bps in 2021, then tumbled -84245bps in 2022.
  • United Health Products' Return on Capital Employed stood at 30.08% in 2021, then crashed by -95bps to 1.39% in 2022, then rose by 6bps to 1.48% in 2023, then fell by -5bps to 1.4% in 2024, then increased by 3bps to 1.45% in 2025.
  • Per Business Quant, the three most recent readings for UEEC's Return on Capital Employed are 1.45% (Q3 2025), 1.62% (Q2 2025), and 1.9% (Q1 2025).